Fidelity Investments’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$123M Buy
17,078,468
+1,139
+0% +$8.18K 0.01% 1028
2025
Q1
$102M Buy
17,077,329
+508,073
+3% +$3.04M 0.01% 1086
2024
Q4
$129M Buy
16,569,256
+8,249,845
+99% +$64.3M 0.01% 1008
2024
Q3
$89.8M Buy
8,319,411
+625,743
+8% +$6.76M 0.01% 1146
2024
Q2
$64.9M Buy
7,693,668
+729,060
+10% +$6.15M ﹤0.01% 1208
2024
Q1
$46.8M Buy
6,964,608
+1,661,754
+31% +$11.2M ﹤0.01% 1349
2023
Q4
$31.2M Buy
5,302,854
+733,073
+16% +$4.31M ﹤0.01% 1469
2023
Q3
$44.6M Buy
4,569,781
+4,248,521
+1,322% +$41.4M ﹤0.01% 1286
2023
Q2
$3.8M Buy
321,260
+275,620
+604% +$3.26M ﹤0.01% 2143
2023
Q1
$492K Sell
45,640
-1,095,851
-96% -$11.8M ﹤0.01% 2696
2022
Q4
$13.2M Sell
1,141,491
-157,552
-12% -$1.82M ﹤0.01% 1781
2022
Q3
$19.4M Buy
1,299,043
+44,693
+4% +$667K ﹤0.01% 1621
2022
Q2
$11.3M Buy
1,254,350
+842,796
+205% +$7.6M ﹤0.01% 1920
2022
Q1
$3.08M Buy
411,554
+22,421
+6% +$168K ﹤0.01% 2489
2021
Q4
$3.34M Buy
389,133
+389,046
+447,179% +$3.34M ﹤0.01% 2455
2021
Q3
$1K Buy
+87
New +$1K ﹤0.01% 4110
2021
Q2
Sell
-3
Closed 4320
2021
Q1
$0 Sell
3
-9,026
-100% ﹤0.01% 4033
2020
Q4
$101K Sell
9,029
-91,067
-91% -$1.02M ﹤0.01% 2879
2020
Q3
$937K Sell
100,096
-125
-0.1% -$1.17K ﹤0.01% 2438
2020
Q2
$184K Hold
100,221
﹤0.01% 2639
2020
Q1
$165K Hold
100,221
﹤0.01% 2593
2019
Q4
$288K Hold
100,221
﹤0.01% 2567
2019
Q3
$578K Buy
100,221
+125
+0.1% +$721 ﹤0.01% 2500
2019
Q2
$1.05M Sell
100,096
-403
-0.4% -$4.22K ﹤0.01% 2442
2019
Q1
$1.77M Sell
100,499
-136,087
-58% -$2.39M ﹤0.01% 2320
2018
Q4
$4.16M Sell
236,586
-366,562
-61% -$6.45M ﹤0.01% 2100
2018
Q3
$24.9M Hold
603,148
﹤0.01% 1592
2018
Q2
$34.6M Hold
603,148
﹤0.01% 1461
2018
Q1
$29M Buy
+603,148
New +$29M ﹤0.01% 1553